BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3178Biotechnology
$17.92 +$1.13 (+6.73%)
Pre-market · Oct 8, 8:20 am ET · After hours $18.50 +3.24%
Open$16.52
Prev close$16.79
Day range$16.42 – $18.37
Volume1.21M
Market cap$1.10B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$10.27M
Operating profit-$31.69M+29.8% YoY
Net profit-$21.97M+35.1% YoY
Diluted EPS-$0.35+36.4% YoY
Free cash flow$12.28M+150.6% YoY
Operating cash flow$12.48M

Revenue, last 8 quarters

$439.0KSep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$10.0MSep '25$0.0Dec '25$3.7MMar '26$10.3MJun '26

Net profit, last 8 quarters

$-28.1MSep '24$-20.2MDec '24$-23.5MMar '25$-33.9MJun '25$-24.3MSep '25$-31.9MDec '25$-24.4MMar '26$-22.0MJun '26

Diluted EPS by quarter

-0.51Sep '24-0.36Dec '24-0.38Mar '25-0.55Jun '25-0.39Sep '25-0.51Dec '25-0.39Mar '26-0.35Jun '26

Free cash flow by quarter

$-2.3MSep '24$-16.8MDec '24$-17.4MMar '25$-24.3MJun '25$-12.9MSep '25$-28.6MDec '25$-12.6MMar '26$12.3MJun '26

Annual revenue

$0.0FY20$3.6MFY21$8.6MFY22$8.1MFY23$10.6MFY24$10.0MFY25

Profitability & balance sheet

Operating margin-598.1%
Net margin-427.5%
Return on equity-10.7%
Return on assets-10.1%
Return on invested capital-14.6%
Current ratio16.35
Liabilities / assets7.9%
Cash & investments$970.91M
Total debt$18.44M
Net cash (debt)$952.48M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $10.27M $3.73M $10.00M $0.00 $10.00M
Total Operating Revenue $10.27M $3.73M $10.00M $0.00 $10.00M
Operating Expense $41.96M $37.95M $167.67M $42.40M $45.25M
Selling and Admin Expenses $10.96M $11.13M $41.77M $10.85M $10.62M
-General & Admin Expense $10.96M $11.13M $41.77M $10.85M $10.62M
Research & Development $30.99M $26.81M $125.90M $31.55M $34.63M
Operating Profit -$31.69M -$34.21M -$157.67M -$42.40M -$35.25M
Net Non-Operating Interest Income (Expense) $9.72M $9.85M $44.04M $10.46M $10.94M
Non-Operating Interest Income $9.72M $9.85M $44.04M $10.46M $10.94M
Pretax Profit -$21.97M -$24.36M -$113.63M -$31.95M -$24.31M
Net Profit -$21.97M -$24.36M -$113.63M -$31.95M -$24.31M
Profit from Continuing Operations -$21.97M -$24.36M -$113.63M -$31.95M -$24.31M
Net Income to Parent Company -$21.97M -$24.36M -$113.63M -$31.95M -$24.31M
Net Income to Common Stockholders -$21.97M -$24.36M -$113.63M -$31.95M -$24.31M
Basic EPS -$0.35 -$0.39 -$1.83 -$0.51 -$0.39
Diluted EPS -$0.35 -$0.39 -$1.83 -$0.51 -$0.39

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $1.01B $1.03B $1.00B $1.00B $1.02B
Total Current Assets $983.34M $1.00B $975.89M $975.89M $998.09M
Cash and Cash Equivalents & Short-Term Investments $970.91M $956.39M $966.57M $966.57M $988.99M
-Cash and Cash Equivalents $27.77M $51.83M $52.33M $52.33M $48.39M
-Short Term Investments $943.15M $904.56M $914.23M $914.23M $940.60M
Receivables $6.33M $42.46M $6.43M $6.43M $6.32M
-Accounts Receivable $149,000.00 $35.00M – – –
-Accrued Interest Receivable $6.18M $7.46M $6.43M $6.43M $6.32M
Prepaid Assets $6.10M $3.20M $2.89M $2.89M $2.78M
Total Non-Current Assets $24.32M $26.18M $25.68M $25.68M $26.68M
Net PPE $20.59M $21.42M $22.25M $22.25M $23.24M
-Gross PPE $28.40M $28.77M $29.22M $29.22M $29.74M
-Accumulated Depreciation -$7.82M -$7.35M -$6.97M -$6.97M -$6.50M
Other Non-Current Assets $3.73M $4.76M $3.42M $3.42M $3.44M
Total Liabilities $79.67M $86.69M $44.74M $44.74M $48.21M
Total Current Liabilities $60.15M $58.92M $25.00M $25.00M $27.83M
Payables $3.02M $3.38M $4.97M $4.97M $3.40M
-Accounts Payable $3.02M $3.38M $4.97M $4.97M $3.40M
Current Accrued Expenses $16.41M $13.23M $13.04M $13.04M $18.13M
Short-Term Debt and Capital Lease Obligation $2.55M $2.47M $2.39M $2.39M $2.28M
-Current Capital Lease Obligation $2.55M $2.47M $2.39M $2.39M $2.28M
Current Deferred Liabilities $35.07M $37.59M – – –
Total Non-Current Liabilities $19.52M $27.78M $19.75M $19.75M $20.38M
Long Term Debt and Capital Lease Obligation $18.44M $19.10M $19.75M $19.75M $20.38M
-Long Term Capital Lease Obligation $18.44M $19.10M $19.75M $19.75M $20.38M
Non-Current Deferred Liabilities $1.08M $8.68M – – –
Total Equity $927.98M $941.54M $956.82M $956.82M $976.56M
Stockholders' Equity $927.98M $941.54M $956.82M $956.82M $976.56M
Capital Stock $61,000.00 $60,000.00 $60,000.00 $60,000.00 $60,000.00
-Common Stock $61,000.00 $60,000.00 $60,000.00 $60,000.00 $60,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.33B $1.32B $1.30B $1.30B $1.29B
Retained Earnings -$397.72M -$375.74M -$351.38M -$351.38M -$319.44M
Gains/Losses Not Affecting Retained Earnings -$2.31M $576,000.00 $4.32M $4.32M $4.56M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $12.48M -$12.34M -$82.24M -$28.54M -$12.86M
Net cash flow from continuing operations $12.48M -$12.34M -$82.24M -$28.54M -$12.86M
Net Income from Continuing Operations -$21.97M -$24.36M -$113.63M -$31.95M -$24.31M
Depreciation & Depletion & Amortization $463,000.00 $469,000.00 $2.03M $468,000.00 $501,000.00
Change in Working Capital $27.82M $4.91M $6.71M -$3.06M $6.54M
-Change in Receivables $34.85M -$35.00M – – –
-Change in Prepaid Assets -$1.61M -$1.34M -$827,000.00 -$227,000.00 $449,000.00
-Change in Payables and Accrued Expense $3.70M -$3.64M $7.27M -$2.85M $6.01M
-Change in Other Current Assets $1.03M -$1.34M $276,000.00 $19,000.00 $66,000.00
-Change In Other Working Capital -$10.16M $46.23M -$2,000.00 $0.00 $9,000.00
Net cash flow from investing -$38.78M $8.29M -$300.98M $29.54M $8.31M
Net Cash Flow from Continuing Investing Activities -$38.78M $8.29M -$300.98M $29.54M $8.31M
Net PPE Purchase and Sale -$202,000.00 -$273,000.00 -$1.04M -$106,000.00 -$93,000.00
Net Investment Purchase and Sale -$38.58M $8.56M -$299.94M $29.65M $8.40M
Financing Cash Flow $2.24M $3.55M $4.95M $2.94M $493,000.00
Net Cash Flow from Continuing Financing Activities $2.24M $3.55M $4.95M $2.94M $493,000.00
Net Common Stock Issuance $0.00 $0.00 -$347,000.00 $0.00 $0.00
Proceeds from Stock Option Exercised $2.24M $3.55M $5.29M $2.94M $493,000.00
Ending Cash Balance $28.58M $52.64M $53.15M $53.15M $49.21M
Net Change in Cash -$24.06M -$506,000.00 -$378.27M $3.95M -$4.06M
Beginning Cash Balance $52.64M $53.15M $431.42M $49.21M $53.26M
Free Cash Flow $12.28M -$12.61M -$83.28M -$28.65M -$12.95M

Discussion

No comments yet — be the first to weigh in on JANX.

Leave a comment

Scroll to Top